Loading...
Header Logo
Keywords
Last Name
Institution

Resham Bhattacharya

TitleProf,Asoc
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentStephenson Cancer Center
Phone405/271-7184
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Bowling Green State University, OhioPhD2002Molecular Microbiology
    University of Calcutta, Calcutta, IndiaMSc1994Zoology/Ecology
    University of Calcutta, Calcutta, IndiaBSc1992Zoology/Chemistry

    Collapse Research 
    Collapse research activities and funding
         Jul 1, 2020 - Jun 30, 2021
    Oklahoma Center for Adult Stem Cell Research, Local
    Exploring the unknown biology of KRCC1; a role in DNA damage response and repair
    Role: Principal Investigator

         Jul 1, 2020 - Jun 30, 2021
    PHF Year Two Team Science Grant Program, Foundation
    Improved Targeting of Ribosome Biogenesis in Cancer
    Role: Co-Investigator

    W81XWH-A8-A-0073     Aug 15, 2018 - Aug 14, 2021
    Department of Defense, Federal
    Phase 1B Trial With PTC-596 in High-Grade Serous Ovarian Cancer: a Targeted Approach Toward Chemoresistant Stem-Like Cancer Cells
    Role: Principal Investigator

    W81XWH-18-1-0054     Aug 15, 2018 - Aug 14, 2021
    Department of Defense, Federal
    Targeting the Stem-Like Cells of Chemoresistant High-Grade Serous Ovarian Cancer: BMI1 in the Spotligh
    Role: Principal Investigator

    R01CA220237-01A1     May 1, 2018 - Apr 30, 2023
    NIH
    UBAP2, A New Molecule in Pancreatic Cancer Progression
    Role: Co-Investigator

    R01CA213278     Dec 22, 2016 - Nov 30, 2021
    NIH/NCI
    Reprogramming Tumor Microenvironment by Nanoparticle
    Role: Co-Investigator

    R01HL120585     Aug 15, 2013 - May 31, 2018
    NIH/NHLBI
    Cystathionine beta synthase (CBS) and angiogenesis
    Role: Co-Investigator

    R01CA157481     Sep 7, 2012 - Jun 30, 2017
    NIH
    Bmi-1, a potential therapeutic target in ovarian cancer
    Role: Principal Investigator

    R01CA136494     Dec 1, 2008 - Nov 30, 2020
    NIH/NCI
    Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hossen MN, Wang L, Chinthalapally HR, Robertson JD, Fung KM, Wilhelm S, Bieniasz M, Bhattacharya R, Mukherjee P. Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome. Sci Adv. 2020 Jul; 6(30):eaba5379. PMID: 32743073.
      View in: PubMed
    2. Xiong X, Rao G, Roy RV, Zhang Y, Means N, Dey A, Tsaliki M, Saha S, Bhattacharyya S, Dhar Dwivedi SK, Rao CV, McCormick DJ, Dhanasekaran D, Ding K, Gillies E, Zhang M, Yang D, Bhattacharya R, Mukherjee P. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer. FASEB J. 2020 Jul 21. PMID: 32692445.
      View in: PubMed
    3. Rao G, Murphy B, Dey A, Dwivedi SKD, Zhang Y, Roy RV, Chakraborty P, Bhattacharya R, Mukherjee P. Cystathionine beta synthase regulates mitochondrial dynamics and function in endothelial cells. FASEB J. 2020 May 28. PMID: 32463541.
      View in: PubMed
    4. Elechalawar CK, Hossen MN, McNally L, Bhattacharya R, Mukherjee P. Analysing the nanoparticle-protein corona for potential molecular target identification. J Control Release. 2020 Jun 10; 322:122-136. PMID: 32165239.
      View in: PubMed
    5. Elechalawar CK, Hossen MN, Shankarappa P, Peer CJ, Figg WD, Robertson JD, Bhattacharya R, Mukherjee P. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. Int J Nanomedicine. 2020; 15:991-1003. PMID: 32103952.
      View in: PubMed
    6. Hossen, M.N., Wang, L., Chinthalapally, H.R., Robertson, J.D., Fung, K.-M., Wilhelm, S., Bieniasz, M., Bhattacharya, R., Mukherjee, P. . Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by Auroliposome. Science Advances. 2020.
    7. Dey, A., Prabhudesai, S.+, Zhang, Y., Rao, G., Thirugnanam, K., Hossen, M. N., Dhar Dwivedi, S. K., Ramchandran, R., Mukherjee, P., Bhattacharya, R. Cystathione ß-synthase regulates HIF-1a stability through persulfidation of PHD2. Science Advances. 2020; 27(6):eaaz8534.
    8. Dwivedi SKD, Shameer K, Dey A, Mustafi SB, Xiong X, Bhattacharya U, Neizer-Ashun F, Rao G, Wang Y, Ivan C, Yang D, Dudley JT, Xu C, Wren JD, Mukherjee P, Bhattacharya R. KRCC1: A potential therapeutic target in ovarian cancer. FASEB J. 2020 Feb; 34(2):2287-2300. PMID: 31908025.
      View in: PubMed
    9. Murphy B, Bhattacharya R, Mukherjee P. Hydrogen sulfide signaling in mitochondria and disease. FASEB J. 2019 12; 33(12):13098-13125. PMID: 31648556.
      View in: PubMed
    10. Wang Y, Hoeppner LH, Angom RS, Wang E, Dutta S, Doeppler HR, Wang F, Shen T, Scarisbrick IA, Guha S, Storz P, Bhattacharya R, Mukhopadhyay D. Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2ß. J Biol Chem. 2019 10 25; 294(43):15759-15767. PMID: 31492751.
      View in: PubMed
    11. Huai Y, Hossen MN, Wilhelm S, Bhattacharya R, Mukherjee P. Nanoparticle Interactions with the Tumor Microenvironment. Bioconjug Chem. 2019 09 18; 30(9):2247-2263. PMID: 31408324.
      View in: PubMed
    12. Huai Y, Zhang Y, Xiong X, Das S, Bhattacharya R, Mukherjee P. Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine. Cell Stress. 2019 Jul 31; 3(8):267-279. PMID: 31440741.
      View in: PubMed
    13. Hossen MN, Rao G, Dey A, Robertson JD, Bhattacharya R, Mukherjee P. Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence. ACS Appl Mater Interfaces. 2019 Jul 24; 11(29):26060-26068. PMID: 31117437.
      View in: PubMed
    14. Zhang Y, Xiong X, Huai Y, Dey A, Hossen MN, Roy RV, Elechalawar CK, Rao G, Bhattacharya R, Mukherjee P. Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro. Bioconjug Chem. 2019 06 19; 30(6):1724-1733. PMID: 31067032.
      View in: PubMed
    15. Neelakantan D, Dogra S, Devapatla B, Jaiprasart P, Mukashyaka MC, Janknecht R, Dwivedi SKD, Bhattacharya R, Husain S, Ding K, Woo S. Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis. Mol Cancer Res. 2019 06; 17(6):1378-1390. PMID: 30858172.
      View in: PubMed
    16. Prabhudesai S, Koceja C, Dey A, Eisa-Beygi S, Leigh NR, Bhattacharya R, Mukherjee P, Ramchandran R. Corrigendum: Cystathionine ß-Synthase Is Necessary for Axis Development in vivo. Front Cell Dev Biol. 2018; 6:121. PMID: 30310813.
      View in: PubMed
    17. Buechel M, Dey A, Dwivedi SKD, Crim A, Ding K, Zhang R, Mukherjee P, Moore KN, Cao L, Branstrom A, Weetall M, Baird J, Bhattacharya R. Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Mol Cancer Ther. 2018 10; 17(10):2136-2143. PMID: 30026381.
      View in: PubMed
    18. Hossen MN, Murphy B, Garci A-Hevia L, Bhattacharya R, Mukherjee P. Probing Cellular Processes Using Engineered Nanoparticles. Bioconjug Chem. 2018 06 20; 29(6):1793-1808. PMID: 29742344.
      View in: PubMed
    19. Hoeppner LH, Sinha S, Wang Y, Bhattacharya R, Dutta S, Gong X, Bedell VM, Suresh S, Chun C, Ramchandran R, Ekker SC, Mukhopadhyay D. Correction: RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells (doi:10.1242/jcs.167601). J Cell Sci. 2018 Mar 16; 131(6). PMID: 29549170.
      View in: PubMed
    20. Chakraborty PK, Murphy B, Mustafi SB, Dey A, Xiong X, Rao G, Naz S, Zhang M, Yang D, Dhanasekaran DN, Bhattacharya R, Mukherjee P. Cystathionine ß-synthase regulates mitochondrial morphogenesis in ovarian cancer. FASEB J. 2018 08; 32(8):4145-4157. PMID: 29494264.
      View in: PubMed
    21. Prabhudesai S, Koceja C, Dey A, Eisa-Beygi S, Leigh NR, Bhattacharya R, Mukherjee P, Ramchandran R. Cystathionine ß-Synthase Is Necessary for Axis Development in Vivo. Front Cell Dev Biol. 2018; 6:14. PMID: 29503817.
      View in: PubMed
    22. Dey A, Xiong X, Crim A, Dwivedi SKD, Mustafi SB, Mukherjee P, Cao L, Sydorenko N, Baiazitov R, Moon YC, Dumble M, Davis T, Bhattacharya R. Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther. 2018 01; 17(1):39-49. PMID: 29158468.
      View in: PubMed
    23. Chakraborty PK, Mustafi SB, Xiong X, Dwivedi SKD, Nesin V, Saha S, Zhang M, Dhanasekaran D, Jayaraman M, Mannel R, Moore K, McMeekin S, Yang D, Zuna R, Ding K, Tsiokas L, Bhattacharya R, Mukherjee P. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634. PMID: 28530221.
      View in: PubMed
    24. Banerjee Mustafi S, Chakraborty PK, Dwivedi SK, Ding K, Moxley KM, Mukherjee P, Bhattacharya R. BMI1, a new target of CK2a. Mol Cancer. 2017 03 07; 16(1):56. PMID: 28270146.
      View in: PubMed
    25. Bhattacharya R, Banerjee K, Mukherjee N, Sen M, Mukhopadhyay A. From molecular insight to therapeutic strategy: The holistic approach for treating triple negative breast cancer. Pathol Res Pract. 2017 Mar; 213(3):177-182. PMID: 28215644.
      View in: PubMed
    26. Saha S, Xiong X, Chakraborty PK, Shameer K, Arvizo RR, Kudgus RA, Dwivedi SK, Hossen MN, Gillies EM, Robertson JD, Dudley JT, Urrutia RA, Postier RG, Bhattacharya R, Mukherjee P. Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. ACS Nano. 2016 12 27; 10(12):10636-10651. PMID: 27758098.
      View in: PubMed
    27. Banerjee Mustafi S, Aznar N, Dwivedi SK, Chakraborty PK, Basak R, Mukherjee P, Ghosh P, Bhattacharya R. Mitochondrial BMI1 maintains bioenergetic homeostasis in cells. FASEB J. 2016 12; 30(12):4042-4055. PMID: 27613804.
      View in: PubMed
    28. Banerjee Mustafi S, Chakraborty PK, Naz S, Dwivedi SK, Street M, Basak R, Yang D, Ding K, Mukherjee P, Bhattacharya R. MDR1 mediated chemoresistance: BMI1 and TIP60 in action. Biochim Biophys Acta. 2016 08; 1859(8):983-93. PMID: 27295567.
      View in: PubMed
    29. Dwivedi SK, Mustafi SB, Mangala LS, Jiang D, Pradeep S, Rodriguez-Aguayo C, Ling H, Ivan C, Mukherjee P, Calin GA, Lopez-Berestein G, Sood AK, Bhattacharya R. Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 2016 Mar 22; 7(12):15093-104. PMID: 26918603.
      View in: PubMed
    30. Dey A, Mustafi SB, Saha S, Kumar Dhar Dwivedi S, Mukherjee P, Bhattacharya R. Inhibition of BMI1 induces autophagy-mediated necroptosis. Autophagy. 2016; 12(4):659-70. PMID: 27050456.
      View in: PubMed
    31. Bhattacharya R, Mustafi SB, Street M, Dey A, Dwivedi SKD. Corrigendum to 'Bmi-1: At the crossroads of physiological and pathological biology' [Genes & Diseases 2 (2015) 225-239]. Genes Dis. 2015 12; 2(4):353. PMID: 30258874.
      View in: PubMed
    32. Chakraborty PK, Xiong X, Mustafi SB, Saha S, Dhanasekaran D, Mandal NA, McMeekin S, Bhattacharya R, Mukherjee P. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget. 2015 Nov 10; 6(35):37367-84. PMID: 26452259.
      View in: PubMed
    33. Saha S, Chakraborty PK, Xiong X, Dwivedi SK, Mustafi SB, Leigh NR, Ramchandran R, Mukherjee P, Bhattacharya R. Cystathionine ß-synthase regulates endothelial function via protein S-sulfhydration. FASEB J. 2016 Jan; 30(1):441-56. PMID: 26405298.
      View in: PubMed
    34. Hoeppner LH, Sinha S, Wang Y, Bhattacharya R, Dutta S, Gong X, Bedell VM, Suresh S, Chun C, Ramchandran R, Ekker SC, Mukhopadhyay D. RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells. J Cell Sci. 2015 10 01; 128(19):3556-68. PMID: 26136364.
      View in: PubMed
    35. Dwivedi SK, McMeekin SD, Slaughter K, Bhattacharya R. Role of TGF-ß signaling in uterine carcinosarcoma. Oncotarget. 2015 Jun 10; 6(16):14646-55. PMID: 25918253.
      View in: PubMed
    36. Bhattacharya R, Mustafi SB, Street M, Dey A, Dwivedi SK. Bmi-1: At the crossroads of physiological and pathological biology. Genes Dis. 2015 Sep; 2(3):225-239. PMID: 26448339.
      View in: PubMed
    37. Xiong X, Arvizo RR, Saha S, Robertson DJ, McMeekin S, Bhattacharya R, Mukherjee P. Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles. Oncotarget. 2014 Aug 15; 5(15):6453-65. PMID: 25071019.
      View in: PubMed
    38. Giri K, Shameer K, Zimmermann MT, Saha S, Chakraborty PK, Sharma A, Arvizo RR, Madden BJ, Mccormick DJ, Kocher JP, Bhattacharya R, Mukherjee P. Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem. 2014 Jun 18; 25(6):1078-90. PMID: 24831101.
      View in: PubMed
    39. Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Basal E, Weaver AL, Visscher DW, Cliby W, Sood AK, Bhattacharya R, Mukherjee P. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One. 2013; 8(11):e79167. PMID: 24236104.
      View in: PubMed
    40. Arvizo RR, Moyano DF, Saha S, Thompson MA, Bhattacharya R, Rotello VM, Prakash YS, Mukherjee P. Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles. J Biol Chem. 2013 Jun 14; 288(24):17610-8. PMID: 23615904.
      View in: PubMed
    41. Arvizo RR, Saha S, Wang E, Robertson JD, Bhattacharya R, Mukherjee P. Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6700-5. PMID: 23569259.
      View in: PubMed
    42. Kudgus RA, Szabolcs A, Khan JA, Walden CA, Reid JM, Robertson JD, Bhattacharya R, Mukherjee P. Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. PLoS One. 2013; 8(3):e57522. PMID: 23483913.
      View in: PubMed
    43. Sinha S, Pal K, Elkhanany A, Dutta S, Cao Y, Mondal G, Iyer S, Somasundaram V, Couch FJ, Shridhar V, Bhattacharya R, Mukhopadhyay D, Srinivas P. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer. 2013 Mar 01; 132(5):1201-12. PMID: 22806981.
      View in: PubMed
    44. Hoeppner LH, Phoenix KN, Clark KJ, Bhattacharya R, Gong X, Sciuto TE, Vohra P, Suresh S, Bhattacharya S, Dvorak AM, Ekker SC, Dvorak HF, Claffey KP, Mukhopadhyay D. Revealing the role of phospholipase Cß3 in the regulation of VEGF-induced vascular permeability. Blood. 2012 Sep 13; 120(11):2167-73. PMID: 22674805.
      View in: PubMed
    45. Arvizo RR, Giri K, Moyano D, Miranda OR, Madden B, McCormick DJ, Bhattacharya R, Rotello VM, Kocher JP, Mukherjee P. Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One. 2012; 7(3):e33650. PMID: 22442705.
      View in: PubMed
    46. Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev. 2012 Apr 07; 41(7):2943-70. PMID: 22388295.
      View in: PubMed
    47. Bhattacharya R, Wang E, Dutta SK, Vohra PK, E G, Prakash YS, Mukhopadhyay D. NHERF-2 maintains endothelial homeostasis. Blood. 2012 May 17; 119(20):4798-806. PMID: 22343917.
      View in: PubMed
    48. Bhattacharyya S, Singh RD, Pagano R, Robertson JD, Bhattacharya R, Mukherjee P. Switching the targeting pathways of a therapeutic antibody by nanodesign. Angew Chem Int Ed Engl. 2012 Feb 13; 51(7):1563-7. PMID: 22135077.
      View in: PubMed
    49. Kudgus RA, Bhattacharya R, Mukherjee P. Cancer nanotechnology: emerging role of gold nanoconjugates. Anticancer Agents Med Chem. 2011 Dec; 11(10):965-73. PMID: 21864234.
      View in: PubMed
    50. Bhattacharyya S, Khan JA, Curran GL, Robertson JD, Bhattacharya R, Mukherjee P. Efficient delivery of gold nanoparticles by dual receptor targeting. Adv Mater. 2011 Nov 16; 23(43):5034-8. PMID: 21971980.
      View in: PubMed
    51. Arvizo RR, Miranda OR, Moyano DF, Walden CA, Giri K, Bhattacharya R, Robertson JD, Rotello VM, Reid JM, Mukherjee P. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One. 2011; 6(9):e24374. PMID: 21931696.
      View in: PubMed
    52. Bhattacharyya S, Gonzalez M, Robertson JD, Bhattacharya R, Mukherjee P. A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity. Chem Commun (Camb). 2011 Aug 14; 47(30):8530-2. PMID: 21717027.
      View in: PubMed
    53. Khan JA, Kudgus RA, Szabolcs A, Dutta S, Wang E, Cao S, Curran GL, Shah V, Curley S, Mukhopadhyay D, Robertson JD, Bhattacharya R, Mukherjee P. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One. 2011; 6(6):e20347. PMID: 21738572.
      View in: PubMed
    54. Wang E, Bhattacharyya S, Szabolcs A, Rodriguez-Aguayo C, Jennings NB, Lopez-Berestein G, Mukherjee P, Sood AK, Bhattacharya R. Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One. 2011 Mar 21; 6(3):e17918. PMID: 21445297.
      View in: PubMed
    55. Arvizo RR, Rana S, Miranda OR, Bhattacharya R, Rotello VM, Mukherjee P. Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine. 2011 Oct; 7(5):580-7. PMID: 21333757.
      View in: PubMed
    56. Patra CR, Jing Y, Xu YH, Bhattacharya R, Mukhopadhyay D, Glockner JF, Wang JP, Mukherjee P. A core-shell nanomaterial with endogenous therapeutic and diagnostic functions. Cancer Nanotechnol. 2010 Dec 01; 1(1):13-18. PMID: 21318050.
      View in: PubMed
    57. Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P. Inorganic nanoparticles in cancer therapy. Pharm Res. 2011 Feb; 28(2):237-59. PMID: 21104301.
      View in: PubMed
    58. Manickam V, Tiwari A, Jung JJ, Bhattacharya R, Goel A, Mukhopadhyay D, Choudhury A. Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood. 2011 Jan 27; 117(4):1425-35. PMID: 21063020.
      View in: PubMed
    59. Bhattacharyya S, Bhattacharya R, Curley S, McNiven MA, Mukherjee P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci U S A. 2010 Aug 17; 107(33):14541-6. PMID: 20679244.
      View in: PubMed
    60. Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, Robertson JD, Rotello VM, Prakash YS, Mukherjee P. Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett. 2010 Jul 14; 10(7):2543-8. PMID: 20533851.
      View in: PubMed
    61. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv. 2010 Jun; 7(6):753-63. PMID: 20408736.
      View in: PubMed
    62. Verma A, Bhattacharya R, Remadevi I, Li K, Pramanik K, Samant GV, Horswill M, Chun CZ, Zhao B, Wang E, Miao RQ, Mukhopadhyay D, Ramchandran R, Wilkinson GA. Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity. Blood. 2010 Jun 03; 115(22):4614-22. PMID: 20086248.
      View in: PubMed
    63. Patra CR, Bhattacharya R, Mukherjee P. Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J Mater Chem. 2010 Jan 01; 20(3):547-554. PMID: 20436942.
      View in: PubMed
    64. Craig TA, Bhattacharya R, Mukhopadhyay D, Kumar R. Sclerostin binds and regulates the activity of cysteine-rich protein 61. Biochem Biophys Res Commun. 2010 Jan 29; 392(1):36-40. PMID: 20043874.
      View in: PubMed
    65. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev. 2010 Mar 08; 62(3):346-61. PMID: 19914317.
      View in: PubMed
    66. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009 Dec 01; 69(23):9090-5. PMID: 19903841.
      View in: PubMed
    67. Sinha S, Vohra PK, Bhattacharya R, Dutta S, Sinha S, Mukhopadhyay D. Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2. J Cell Sci. 2009 Sep 15; 122(Pt 18):3385-92. PMID: 19706677.
      View in: PubMed
    68. Bhattacharya R, Kwon J, Li X, Wang E, Patra S, Bida JP, Bajzer Z, Claesson-Welsh L, Mukhopadhyay D. Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci. 2009 Apr 01; 122(Pt 7):1025-34. PMID: 19295129.
      View in: PubMed
    69. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, Shridhar V, Mukherjee P. Role of hedgehog signaling in ovarian cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7659-66. PMID: 19047091.
      View in: PubMed
    70. Basu N, Bhattacharya R, Mukherjee P. Protein-mediated autoreduction of gold salts to gold nanoparticles. Biomed Mater. 2008 Sep; 3(3):034105. PMID: 18689931.
      View in: PubMed
    71. Bhattacharya R, Sinha S, Yang SP, Patra C, Dutta S, Wang E, Mukhopadhyay D. The neurotransmitter dopamine modulates vascular permeability in the endothelium. J Mol Signal. 2008 Jul 28; 3:14. PMID: 18662404.
      View in: PubMed
    72. Bhattacharya R, Mukherjee P. Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev. 2008 Aug 17; 60(11):1289-306. PMID: 18501989.
      View in: PubMed
    73. Bhattacharya R, Kwon J, Wang E, Mukherjee P, Mukhopadhyay D. Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J Mol Signal. 2008 Mar 31; 3:8. PMID: 18377662.
      View in: PubMed
    74. Patra CR, Bhattacharya R, Wang E, Katarya A, Lau JS, Dutta S, Muders M, Wang S, Buhrow SA, Safgren SL, Yaszemski MJ, Reid JM, Ames MM, Mukherjee P, Mukhopadhyay D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 2008 Mar 15; 68(6):1970-8. PMID: 18339879.
      View in: PubMed
    75. Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnology. 2008 Jan 30; 6:2. PMID: 18234109.
      View in: PubMed
    76. Patra CR, Bhattacharya R, Patra S, Basu S, Mukherjee P, Mukhopadhyay D. Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research. Clin Chem. 2007 Nov; 53(11):2029-31. PMID: 18035595.
      View in: PubMed
    77. Mukherjee P, Bhattacharya R, Bone N, Lee YK, Patra CR, Wang S, Lu L, Secreto C, Banerjee PC, Yaszemski MJ, Kay NE, Mukhopadhyay D. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology. 2007 May 08; 5:4. PMID: 17488514.
      View in: PubMed
    78. Muders MH, Dutta SK, Wang L, Lau JS, Bhattacharya R, Smyrk TC, Chari ST, Datta K, Mukhopadhyay D. Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res. 2006 Nov 01; 66(21):10264-8. PMID: 17079444.
      View in: PubMed
    79. Patra CR, Bhattacharya R, Patra S, Basu S, Mukherjee P, Mukhopadhyay D. Inorganic phosphate nanorods are a novel fluorescent label in cell biology. J Nanobiotechnology. 2006 Oct 30; 4:11. PMID: 17074086.
      View in: PubMed
    80. Bhattacharya R, Kang-Decker N, Hughes DA, Mukherjee P, Shah V, McNiven MA, Mukhopadhyay D. Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J. 2005 Oct; 19(12):1692-4. PMID: 16049137.
      View in: PubMed
    81. Bhattacharya R, Senbanerjee S, Lin Z, Mir S, Hamik A, Wang P, Mukherjee P, Mukhopadhyay D, Jain MK. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem. 2005 Aug 12; 280(32):28848-51. PMID: 15980434.
      View in: PubMed
    82. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 2005 May 01; 11(9):3530-4. PMID: 15867256.
      View in: PubMed
    83. Mukhopadhyay D, Zeng H, Bhattacharya R. Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling. Mol Cell Biochem. 2004 Sep; 264(1-2):51-61. PMID: 15544035.
      View in: PubMed
    84. Datta K, Li J, Bhattacharya R, Gasparian L, Wang E, Mukhopadhyay D. Protein kinase C zeta transactivates hypoxia-inducible factor alpha by promoting its association with p300 in renal cancer. Cancer Res. 2004 Jan 15; 64(2):456-62. PMID: 14744756.
      View in: PubMed
    Bhattacharya's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description